维普中文期刊产品整合服务
243篇 您的检索式:作者名="Fineman"
    题名 作者 年代 出处 被引量
1经年之后,平等仍未实现--公民权、自主权与性别权利之辩显示文摘尽管争取性别平等、反对权力分配中的性别歧视已经40多年,但植根于社会、意识形态、制度结构包括法律中的性别依附和男性主宰的政治仍然存在。为什么这么多年来,经过平等理论的建构、辩论和行动计划的实施,实现性别平等仍然是如此的虚幻呢?部分的原因就在于现行的争取性别平等的斗争受到前人形成和传承的哲学、法理观念的束缚。本文提出了一个更实际的实现性别平等的办法,即跳出性别,在人性普遍的脆弱性上建立一个更广泛的框架。这种新的理论研究聚焦于特权和歧视,考察社会组织和制度结构在利益分配中的影响。这种方法可促使我们在美国社会中更好地获得实质的平等权和社会权利。玛萨·艾伯森·法曼(Martha Albertson Fineman) 王新宇(译) 2014比较法研究2014,28,3:3
2Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus显示文摘Orville G. Kolterman Dennis D. Kim Larry Shen James A. Ruggles Loretta L. Nielsen Mark S. Fineman Alain D. Baron 2005American Journal of Health-System Pharmacy2005,,2:2
3Effect on glycemic control of synthetic Exendin-4 (AC2993) additive to existing metforrnin and/or sulfonylurea treatment in patients with type 2 diabetes显示文摘Fineman MS Bicsak TA Shen LZ 2003Diabetes Care2003,26,8:1
4Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes显示文摘Ratner R Want LL Fineman MS 2002Diabetes Technol Ther2002,4,1:1
5Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus 显示文摘Koherman OG Kim DD Shen L Ruggles JA Nielsen LL Fineman MS 2005Am J Health Syst Pharm2005,62,2:1
6Collagen sponge repair of small cerebrospinal fluid leaks obviates tissue grafts and cerebrospinal fluid diversion after pituitary surgery 显示文摘 Oskouian R J Fineman I 2001Neurosurgery2001,49,4:1
7Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes:a dose-timing study显示文摘Maggs DG Fineman M Kornstein J 2004Diabetes Metab Res Rev2004,20,1:1
8Determination of the hydrophile-lipophile character of surface active agents and oils by a water titration显示文摘GREENWALD H L BROWN G L FINEMAN M N 1976Anal Chem1976,,7:1
9Pharmacokinetics of an Oral Drug(Acetaminophen) Administered at Various Times in Relation to Subcutaneous Injection of Exenatide (Exendin-4) in Healthy Subjects显示文摘Erich Blase Kristin Taylor Hong-ye Gao Matthew Wintle Mark Fineman 2005The Journal Of Clinical Pharmacology2005,,5:1
10Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus:a 1-year,randomized controlled trial显示文摘Ratner RE Dickey R Fineman M 2004Diabet Med2004,21,11:1
11Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes:a 1-year randomized controlled trial显示文摘Hollander PA Levy P Fineman MS 2003Diabates Care2003,26,3:1
12The pathophysiology of pulmonary hypertension in congenital heart disease 显示文摘Steinhom RH Fineman JR 1999Artif Organs1999,23,:1
13Effectiveness of progressive does-escalation of exenatide ( exendin-4 ) in reducing doselimiting side effects in patients with type 2 diabetes 显示文摘Fineman MS Shen LZ Taylor K 2004J Diabetes Metab Res Rev2004,20,5:1
14Short-term outcomes of 25-gauge vitreetomy with silicone oil for repair of complicated retinal detachment 显示文摘Shah C Ho A Regillo C Fineman M Vander J Brown G 2008Retina2008,28,5:1
15Inhaled nitric oxide and persistent pulmonary hypertension of the newborn显示文摘Roberts JD Fineman JR Morin FC 1997N Engl J Med1997,336,10:1
16Adjunctive therapy with pramlintide lowers HbAlc without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets 显示文摘Ratner R Whitehouse F Fineman MS 2005Exp Clin Endocrinol Diabetes2005,113,4:1
17A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes显示文摘Whitehouse F Kruger DF Fineman M 2002Diabetes Care2002,25,4:1
18Economic implications of increased longevity in the United States显示文摘Rice DP Fineman N 0,,:1
19Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial 显示文摘Hollander PA Levy P Fineman MS 2003Diabetes Care2003,26,3:1
20Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery显示文摘Fineman MS Brown GC 2006Ophthalmology2006,113,1:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费